Skip to main content

Table 2 Heart dimensions and function

From: Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

 Wt/wtWt/wt + ATIIDb/dbDb/db + DAPADb/db + ATIIDb/db + ATII + DAPA
Numbers665466
IVS0.9 ± 0.11.2 ± 0.08&0.96 ± 0.080.97 ± 0.11.2 ± 0.1#1.2 ± 0.2
LVPW0.8 ± 0.051.1 ± 0.12&0.9 ± 0.10.9 ± 0.31.1 ± 0.1#1.2 ± 0.3
LVEDD3.8 ± 0.23.4 ± 0.33.5 ± 0.53.7 ± 0.63.7 ± 0.43.4 ± 0.6
LVESD2.4 ± 0.12.3 ± 0.32.1 ± 0.52.2 ± 0.52.4 ± 0.31.9 ± 0.5*
FS36.2 ± 2.231.9 ± 4.939.4 ± 6.239.7 ± 6.334.9 ± 2.645.9 ± 6.5*
  1. * p < 0.05 vs db/db ± ATII, #p < 0.05 vs db/db, &p < 0.05 vs wt/wt